Cholinergic Receptor Muscarinic 4 (CHRM4) Antibody
260€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Cholinergic Receptor Muscarinic 4 (CHRM4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx242455
tested applications
ELISA, WB
Description
CHRM4 Antibody is a Rabbit Polyclonal against CHRM4.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Cholinergic Receptor Muscarinic 4 (CHRM4) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | ELISA: 1/500 - 1/5000, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Antigen Affinity Chromatography. |
| Size 1 | 50 µl |
| Size 2 | 100 µl |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P08173 |
| Gene ID | 1132 |
| Alias | CHRM4,Chrm-4,cholinergic receptor, muscarinic 4,cholinergic receptor,M4 receptor,HM4, M4R |
| Background | Antibody anti-CHRM4 |
| Status | RUO |
Descripción
CHRM4 encodes the muscarinic acetylcholine receptor M4, a member of the G protein-coupled receptor (GPCR) family that predominantly couples with Gi/o proteins. When activated by acetylcholine, CHRM4 inhibits adenylate cyclase, leading to a decrease in intracellular cyclic AMP (cAMP) levels and subsequent regulation of cellular excitability. CHRM4 is widely expressed in the central nervous system (CNS), particularly in regions like the striatum, basal ganglia, and hippocampus, where it plays a pivotal role in dopaminergic signaling and motor control. CHRM4 is a crucial modulator of dopamine release and has gained interest as a therapeutic target for disorders such as Parkinson's disease, schizophrenia, and addiction. In preclinical models, CHRM4 activation has been shown to suppress dopamine overactivity, which is associated with psychotic symptoms in schizophrenia. CHRM4 also plays roles in mood regulation, cognition, and neuromodulation by influencing cholinergic-dopaminergic interactions. Genetic variations in CHRM4 may affect susceptibility to neuropsychiatric diseases. Pharmacologically, CHRM4-selective agonists are under exploration for their ability to normalize dopamine levels, while antagonists have been evaluated for their effects on smooth muscle tone in peripheral tissues.
Related Products
Muscarinic Acetylcholine Receptor M4 (CHRM4) Antibody
CHRM4 Antibody is a Rabbit Polyclonal Antibody against CHRM4.
Ver Producto
Muscarinic Acetylcholine Receptor M4 (CHRM4) Antibody
Rabbit polyclonal antibody against CHRM4 protein. Immunogen region is Internal.
Ver Producto
Cholinergic Receptor Muscarinic 4 (CHRM4) Antibody
CHRM4 Antibody is a Rabbit Polyclonal against CHRM4.
Ver Producto